Utah Medical Products, Inc.UTMDNASDAQ
Loading
P/E Ratio HistoryFair Value
Percentile Rank21
3Y CAGR-9.6%
5Y CAGR-10.5%
Studio
Year-over-Year Change

Price-to-earnings ratio

3Y CAGR
-9.6%/yr
vs +7.4%/yr prior
5Y CAGR
-10.5%/yr
Consistent
Acceleration
-16.9pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthFair Value
PeriodValueYoY Change
202516.41+5.7%
202415.52-15.7%
202318.41-17.0%
202222.20-10.0%
202124.66-13.6%
202028.56+4.8%
201927.26+63.2%
201816.70-53.1%
201735.58+58.1%
201622.50-